• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

NT PHARMA(01011.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Aug8
NT PHARMA released FY2025 Q1 earnings on August 8 (BJT), actual revenue HKD 6.423 M, actual EPS HKD -0.0162
15:00
Tailem Pharma Reports Increased Mid-Year Loss
08:45
NT PHARMA released FY2025 Q2 earnings on August 8 During-Market (BJT), actual revenue HKD 6.564 M, actual EPS HKD -0.0165
08:00
NT PHARMA released FY2025 Semi-Annual earnings on August 8 During-Market (BJT), actual revenue HKD 12.99 M, actual EPS HKD -0.0327
08:00
Jul31
NT PHARMA to Release FY2025 Semi-Annual Earnings on August 8, 2025 (BJT)
00:59
Jul30
Tailem Pharma Cooperates with State-Owned Enterprise to Launch Smart Healthcare Center
14:07

Schedules & Filings

Schedules
Filings
Aug8
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 6.564 M, Net Income -9.252 M, EPS -0.0165

Mar31
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 3.544 M, Net Income -28.73 M, EPS -0.1088

Aug30
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 16.81 M, Net Income 355.13 K, EPS 0.0013

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00312
0.081
+68.75%
+0.033
01271
1.270
+45.98%
+0.400
00191
0.720
+44.00%
+0.220
01725
1.000
+42.86%
+0.300
01045
3.740
+34.53%
+0.960
08460
3.000
+32.74%
+0.740
00498
0.155
+29.17%
+0.035
02478
1.620
+26.56%
+0.340
08429
0.070
+25.00%
+0.014
08311
0.098
+24.05%
+0.019
View More